Sources: Drug Shortages | FDA FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize | FDA Facts About the Current Good Manufacturing Practice (CGMP) | FDA FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products | FDA FDA and Novo Nordisk Warned of GLP-1 Telehealth Compounding Takedown
Mazdutide availability Mazdutide received approval in China in June 2025, marketed under the brand name Xinermei by Innovent Biologics
received research support from Cerenovus Inc, Medtronic, Endovascular Engineering, Frontier Bio, Sensome Inc, Endomimetics, Ancure LLC, Neurogami Medical, MIVI Biosciences, Monarch Biosciences, Stryker, Conway Medical, Piraeus Medical, Rion Inc, and Bionaut Labs
This domain represents a particularly intriguing frontier, as it intersects with broader questions about the role of metal-binding peptides in neural integrity
For longer-term support: chicory inulin Chicory inulin is the only fiber with an EU-authorised claim for bowel function, chicory inulin contributes to normal bowel function by increasing stool frequency, at 12g/day
Current evidence suggests tolerance doesnt develop
